Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 2
1996 2
1997 3
1998 7
1999 8
2000 7
2001 7
2002 12
2003 10
2004 11
2005 18
2006 9
2007 15
2008 25
2009 21
2010 19
2011 17
2012 12
2013 19
2014 15
2015 11
2016 17
2017 19
2018 8
2019 11
2020 12
2021 8
2022 8
2023 10
2024 14
2025 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

318 results

Results by year

Filters applied: . Clear all
Page 1
S2k-Leitlinie Lebertransplantation der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV).
Berg T, Aehling NF, Bruns T, Welker MW, Weismüller T, Trebicka J, Tacke F, Strnad P, Sterneck M, Settmacher U, Seehofer D, Schott E, Schnitzbauer AA, Schmidt HH, Schlitt HJ, Pratschke J, Pascher A, Neumann U, Manekeller S, Lammert F, Klein I, Kirchner G, Guba M, Glanemann M, Engelmann C, Canbay AE, Braun F, Berg CP, Bechstein WO, Becker T, Trautwein C; Collaborators:. Berg T, et al. Z Gastroenterol. 2024 Sep;62(9):1397-1573. doi: 10.1055/a-2255-7246. Epub 2024 Sep 9. Z Gastroenterol. 2024. PMID: 39250961 Free article. German. No abstract available.
Aktualisierte S2k-Leitlinie nicht-alkoholische Fettlebererkrankung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – April 2022 – AWMF-Registernummer: 021–025.
Roeb E, Canbay A, Bantel H, Bojunga J, de Laffolie J, Demir M, Denzer UW, Geier A, Hofmann WP, Hudert C, Karlas T, Krawczyk M, Longerich T, Luedde T, Roden M, Schattenberg J, Sterneck M, Tannapfel A, Lorenz P, Tacke F; Collaborators:. Roeb E, et al. Z Gastroenterol. 2022 Sep;60(9):1346-1421. doi: 10.1055/a-1880-2283. Epub 2022 Sep 13. Z Gastroenterol. 2022. PMID: 36100202 Free article. German. No abstract available.
Amendment „Neue Nomenklatur zur MASLD (Metabolic Dysfunction Associated Steatotic Liver Disease; metabolische Dysfunktion assoziierte steatotische Lebererkrankung)“ zur S2k-Leitlinie „Nicht-alkoholische Fettlebererkrankung“ (v.2.0/April 2022) der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS).
Roeb E, Canbay A, Bantel H, Bojunga J, de Laffolie J, Demir M, Denzer UW, Geier A, Hofmann WP, Hudert C, Karlas T, Krawczyk M, Longerich T, Lüdde T, Roden M, Schattenberg JM, Sterneck M, Tannapfel A, Lorenz P, Tacke F; Collaborators. Roeb E, et al. Z Gastroenterol. 2024 Jul;62(7):1077-1087. doi: 10.1055/a-2309-6052. Epub 2024 Jul 8. Z Gastroenterol. 2024. PMID: 38976985 German. No abstract available.
Decoding pan-cancer treatment outcomes using multimodal real-world data and explainable artificial intelligence.
Keyl J, Keyl P, Montavon G, Hosch R, Brehmer A, Mochmann L, Jurmeister P, Dernbach G, Kim M, Koitka S, Bauer S, Bechrakis N, Forsting M, Führer-Sakel D, Glas M, Grünwald V, Hadaschik B, Haubold J, Herrmann K, Kasper S, Kimmig R, Lang S, Rassaf T, Roesch A, Schadendorf D, Siveke JT, Stuschke M, Sure U, Totzeck M, Welt A, Wiesweg M, Baba HA, Nensa F, Egger J, Müller KR, Schuler M, Klauschen F, Kleesiek J. Keyl J, et al. Among authors: baba ha. Nat Cancer. 2025 Feb;6(2):307-322. doi: 10.1038/s43018-024-00891-1. Epub 2025 Jan 30. Nat Cancer. 2025. PMID: 39885364 Free PMC article.
[Liver biopsy diagnostics-times are changing].
Longerich T, Baba HA. Longerich T, et al. Among authors: baba ha. Pathologe. 2020 Sep;41(5):432-433. doi: 10.1007/s00292-020-00804-w. Pathologe. 2020. PMID: 32822014 German. No abstract available.
Exploring the impact of durvalumab on biliary tract cancer: insights from real-world clinical data.
Reimann P, Mavroeidi IA, Burghofer J, Taghizadeh H, Webersinke G, Kasper S, Schreil G, Morariu D, Reichinger A, Baba HA, Kirchweger P, Schuler M, Djanani A, Prager GW, Rumpold H, Benda M, Schneider EM, Mink S, Winder T, Doleschal B. Reimann P, et al. Among authors: baba ha. Cancer Immunol Immunother. 2024 Oct 3;73(12):251. doi: 10.1007/s00262-024-03842-y. Cancer Immunol Immunother. 2024. PMID: 39358611 Free PMC article.
[Pathology of the cardiovascular system].
Wohlschläger J, Baba HA. Wohlschläger J, et al. Among authors: baba ha. Pathologe. 2012 May;33(3):173-4. doi: 10.1007/s00292-011-1553-9. Pathologe. 2012. PMID: 22527028 German. No abstract available.
Primäres Burkitt-Lymphom des Herzens - Diagnose und Therapie.
Hoffmeier A, Semik M, Schmid Ch, Mesters RM, Castrucci M, Baba HA, Fallenberg EM, Scheld HH. Hoffmeier A, et al. Among authors: baba ha. Z Kardiol. 2002 Apr;91(4):347-51. doi: 10.1007/s003920200037. Z Kardiol. 2002. PMID: 24756421 German.
318 results